With your continued support, we can make every U.S. breast cancer trial available on our clinical trial search platform and bring you the most relevant and trusted news and information to help people understand and access these trials.
Do you need surgery or radiation to the breast after an MBC diagnosis? See the current research on this important question.
Match to new biomarkers, new sites of metastatic spread, and measurable disease. Now easier to use on a phone, laptop and desktop.
Treatments for metastatic cancer can affect a person’s body image. Find relevant research and read about how some MBC patients think about body image and make choices.
Read about current efforts advocating for giving the right dose of MBC medications to maximize effectiveness and minimize toxicity.
On November 13, 2020, the FDA approved pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of patients with locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC) whose tumors express PD-L1 as determined by an FDA approved test.
People with MBC may find that creativity can help them cope. Learn more here and find out how to find clinical trials studying ways to improve quality of life.
People with MBC may find that creativity can help them cope. Learn more here and find out how to find clinical trials studying ways to improve quality of life.
New research shows that stage 4 breast cancer with HER2-low expression can benefit from a new drug. Learn more.
SABCS 2020 will be held virtually December 8-11, 2020. Find tips and information to get prepared for this major breast cancer conference.
